132 related articles for article (PubMed ID: 20142253)
1. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
Phelan CM; Tsai YY; Goode EL; Vierkant RA; Fridley BL; Beesley J; Chen XQ; Webb PM; Chanock S; Cramer DW; Moysich K; Edwards RP; Chang-Claude J; Garcia-Closas M; Yang H; Wang-Gohrke S; Hein R; Green AC; Lissowska J; Carney ME; Lurie G; Wilkens LR; Ness RB; Pearce CL; Wu AH; Van Den Berg DJ; Stram DO; Terry KL; Whiteman DC; Whittemore AS; DiCioccio RA; McGuire V; Doherty JA; Rossing MA; Anton-Culver H; Ziogas A; Hogdall C; Hogdall E; Krüger Kjaer S; Blaakaer J; Quaye L; Ramus SJ; Jacobs I; Song H; Pharoah PD; Iversen ES; Marks JR; Pike MC; Gayther SA; Cunningham JM; Goodman MT; Schildkraut JM; Chenevix-Trench G; Berchuck A; Sellers TA; ;
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):600-4. PubMed ID: 20142253
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Palmieri RT; Wilson MA; Iversen ES; Clyde MA; Calingaert B; Moorman PG; Poole C; Anderson AR; Anderson S; Anton-Culver H; Beesley J; Hogdall E; Brewster W; Carney ME; Chen X; Chenevix-Trench G; Chang-Claude J; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Edlund CK; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Kjaer SK; Hogdall CK; Hopkins MP; Jenison EL; Blaakaer J; Lurie G; McGuire V; Menon U; Moysich KB; Ness RB; Pearce CL; Pharoah PD; Pike MC; Ramus SJ; Rossing MA; Song H; Terada KY; Vandenberg D; Vierkant RA; Wang-Gohrke S; Webb PM; Whittemore AS; Wu AH; Ziogas A; Berchuck A; Schildkraut JM; ; ;
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3567-72. PubMed ID: 19064572
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
Pearce CL; Doherty JA; Van Den Berg DJ; Moysich K; Hsu C; Cushing-Haugen KL; Conti DV; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PD; Song H; Kjaer SK; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Sieh W; Gronwald J; Medrek K; Jakubowska A; Lubinski J; Chenevix-Trench G; ; Beesley J; Webb PM; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Edlund CK; Stram DO; Pike MC; Ness RB; Rossing MA; Wu AH
Hum Mol Genet; 2011 Jun; 20(11):2263-72. PubMed ID: 21422097
[TBL] [Abstract][Full Text] [Related]
4. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.
Sellers TA; Huang Y; Cunningham J; Goode EL; Sutphen R; Vierkant RA; Kelemen LE; Fredericksen ZS; Liebow M; Pankratz VS; Hartmann LC; Myer J; Iversen ES; Schildkraut JM; Phelan C
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):397-404. PubMed ID: 18268124
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
Amankwah EK; Wang Q; Schildkraut JM; Tsai YY; Ramus SJ; Fridley BL; Beesley J; Johnatty SE; Webb PM; Chenevix-Trench G; ; Dale LC; Lambrechts D; Amant F; Despierre E; Vergote I; Gayther SA; Gentry-Maharaj A; Menon U; Chang-Claude J; Wang-Gohrke S; Anton-Culver H; Ziogas A; Dörk T; Dürst M; Antonenkova N; Bogdanova N; Brown R; Flanagan JM; Kaye SB; Paul J; Bützow R; Nevanlinna H; Campbell I; Eccles DM; Karlan BY; Gross J; Walsh C; Pharoah PD; Song H; Krüger Kjær S; Høgdall E; Høgdall C; Lundvall L; Nedergaard L; Kiemeney LA; Massuger LF; van Altena AM; Vermeulen SH; Le ND; Brooks-Wilson A; Cook LS; Phelan CM; Cunningham JM; Vachon CM; Vierkant RA; Iversen ES; Berchuck A; Goode EL; Sellers TA; Kelemen LE
PLoS One; 2011; 6(5):e19642. PubMed ID: 21637745
[TBL] [Abstract][Full Text] [Related]
6. Association of a common variant of SYNPO2 gene with increased risk of serous epithelial ovarian cancer.
Ma L; Zhang W; Ding Z; Wu SG; Jin Y; Jiang N; Du H; Cai D; Miao L; Chen X
Tumour Biol; 2017 Feb; 39(2):1010428317691185. PubMed ID: 28231729
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.
Lurie G; Wilkens LR; Thompson PJ; Carney ME; Palmieri RT; Pharoah PD; Song H; Hogdall E; Kjaer SK; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Goodman MT;
Int J Cancer; 2011 Feb; 128(4):936-43. PubMed ID: 20473893
[TBL] [Abstract][Full Text] [Related]
9. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Wang ZQ; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Bachvarov D
Oncotarget; 2014 Jan; 5(2):544-60. PubMed ID: 24504219
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
Poole EM; Gates MA; High BA; Chanock SJ; Cramer DW; Cunningham JM; Fridley BL; Gayther SA; Goode EL; Iversen ES; Lissowska J; Palmieri Weber RT; Pharoah PD; Phelan CM; Ramus SJ; Schildkraut JM; Sutphen R; Tsai YY; Tyrer J; Vierkant RA; Wentzensen N; Yang HP; Terry KL; Tworoger SS
Cancer Causes Control; 2012 Nov; 23(11):1805-10. PubMed ID: 22961099
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Johnatty SE; Beesley J; Chen X; Macgregor S; Duffy DL; Spurdle AB; deFazio A; Gava N; Webb PM; Rossing MA; Doherty JA; Goodman MT; Lurie G; Thompson PJ; Wilkens LR; Ness RB; Moysich KB; Chang-Claude J; Wang-Gohrke S; Cramer DW; Terry KL; Hankinson SE; Tworoger SS; Garcia-Closas M; Yang H; Lissowska J; Chanock SJ; Pharoah PD; Song H; Whitemore AS; Pearce CL; Stram DO; Wu AH; Pike MC; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Anton-Culver H; Ziogas A; Hogdall E; Kjaer SK; Hogdall C; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Phelan CM; Sellers TA; Cunningham JM; Vierkant RA; Rider DN; Goode EL; Haviv I; Chenevix-Trench G; ; ;
PLoS Genet; 2010 Jul; 6(7):e1001016. PubMed ID: 20628624
[TBL] [Abstract][Full Text] [Related]
12. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PD; Webb PM; Chenevix-Trench G; ; ;
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2557-65. PubMed ID: 18086758
[TBL] [Abstract][Full Text] [Related]
13. Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk.
Earp MA; Brooks-Wilson A; Cook L; Le N
BMC Res Notes; 2013 Oct; 6():425. PubMed ID: 24148579
[TBL] [Abstract][Full Text] [Related]
14. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PD; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; ; ; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):245-50. PubMed ID: 20056644
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism at miRNA-122-binding site in the IL-1α 3'UTR is associated with risk of epithelial ovarian cancer.
Zhang Z; Zhou B; Gao Q; Wu Y; Zhang K; Pu Y; Song Y; Zhang L; Xi M
Fam Cancer; 2014 Dec; 13(4):595-601. PubMed ID: 25195148
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
Grant DJ; Hoyo C; Akushevich L; Iversen ES; Whitaker R; Marks J; Berchuck A; Schildkraut JM
Gynecol Oncol; 2013 Apr; 129(1):173-8. PubMed ID: 23262379
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the MUC16 gene: potential implication in epithelial ovarian cancer.
Bouanene H; Hadj Kacem H; Ben Fatma L; Ben Limem H; Ben Ahmed S; Yakoub S; Miled A
Pathol Oncol Res; 2011 Jun; 17(2):295-9. PubMed ID: 21046495
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q
Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
